21st Century Cures Act Will Jumpstart U.S. Medical Innovation

WASHINGTON, DC – The National Venture Capital Association (NVCA) today issued the following statement after the House of Representatives overwhelmingly passed H.R. 6, the 21st Century Cures Act of 2015.

“Today’s passage in the House of the 21st Century Cures Act is a huge win for the U.S. medical innovation ecosystem and an example of bipartisanship at work to address some of our nation’s most pressing challenges,” said Bobby Franklin, President and CEO of NVCA.  “By increasing NIH funding and improving the environment for drug development, this bill goes a long way in ensuring the U.S. remains the global hub of medical innovation.  We congratulate Chairman Upton and Rep. DeGette for this tremendous achievement and thank them for pushing the ball forward on this important issue.”